Biocon Biologics, Civica join hands to expand Insulin Aspart access in US Ruchika Sharma7 March 2025 11:30 AM ISTCivica will commercialize the medicine for patients in the United States, after completion of development work and clinical trials.
Wockhardt gets CDSCO Panel nod to study Biphasic insulin aspart Dr. Divya Colin15 March 2024 5:30 PM ISTNew Delhi: Reviewing the protocol presented by the drug major Wockhardt, the Subject Expert Committee (SEC) functional under the Central Drug Standard...
USV Launches INSUQUICK, First Biosimilar Insulin Aspart in India MD Brand Connect1 Nov 2023 5:39 PM ISTUSV Pvt. Ltd, leaders in oral anti-diabetes segment, has announced the launch of 1st biosimilar Insulin Aspart in India, INSUQUICK, for the...
Biocon Biologics gets Complete Response Letter from USFDA for bosimilar Insulin Aspart Ruchika Sharma9 Oct 2023 11:30 AM ISTBengaluru: Biocon Biologics has announced that the U.S. Food and Drug Administration (US FDA) has issued a Complete Response Letter (CRL) for the...
Faster aspart tied to better glycemic control than insulin aspart for gestational diabetes Aditi30 Dec 2022 10:30 AM ISTKerala:A study published in Current Diabetes Reviews has concluded that, in women with gestational diabetes, Faster aspart is associated with better...
Sanofi gets CDSCO panel nod to market Biphasic Insulin Aspart Injection Dr. Divya Colin8 Nov 2022 6:00 PM ISTNew Delhi: With a condition of conducting a phase IV study, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Biocon arm gets multiple USFDA observations across India, Malaysia Ruchika Sharma1 Sept 2022 5:00 PM ISTBiocon said the inspections were on account of three pre-approval inspections for biosimilar Bevacizumab, rh-Insulin and Insulin Aspart and a capacity...
Biocon, Viatris application for Insulin Aspart rejected by USFDA Ruchika Sharma11 Jan 2022 3:30 PM ISTNew Delhi: Biocon Biologics, a subsidiary of biotechnology major Biocon, on Friday said the US health regulator has not approved an application for...
